Enzo Biochem, Inc [ENZ] stock prices are up 24.23% to $0.32 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ENZ shares have gain 11.72% over the last week, with a monthly amount drifted -29.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Enzo Biochem, Inc [NYSE: ENZ] stock has seen the most recent analyst activity on October 18, 2011, when Rodman & Renshaw reiterated its Mkt Outperform rating and also revised its price target to $5 from $7. Previously, Rodman & Renshaw started tracking the stock with Mkt Outperform rating on September 23, 2009, and set its price target to $14. On September 13, 2007, Lazard Capital initiated with a Buy rating and assigned a price target of $19 on the stock.
The stock price of Enzo Biochem, Inc [ENZ] has been fluctuating between $0.25 and $1.16 over the past year. Enzo Biochem, Inc [NYSE: ENZ] shares were valued at $0.32 at the most recent close of the market.
Analyzing the ENZ fundamentals
The Enzo Biochem, Inc [NYSE:ENZ] reported sales of 29.09M for trailing twelve months, representing a drop of -14.25%. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at -0.3%, Pretax Profit Margin comes in at -0.26%, and Net Profit Margin reading is -0.73%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.39 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2983 points at the first support level, and at 0.2727 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3373, and for the 2nd resistance point, it is at 0.3507.
Ratios To Look Out For
It’s worth pointing out that Enzo Biochem, Inc [NYSE:ENZ]’s Current Ratio is 3.04. Further, the Quick Ratio stands at 2.69, while the Cash Ratio is 2.35. Considering the valuation of this stock, the price to sales ratio is 0.58, the price to book ratio is 0.36.
